Gene therapy: Ethical aspects and problems of genetic safety

Genetika

Volumn 35, Issue 12, 1999, Pages 1605-1612

  Zelenin, A V ^a  

^a ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

GENE THERAPY; HUMAN; MEDICAL ETHICS; REVIEW;

ETHICS, MEDICAL; GENE THERAPY; HUMANS;

EID: 0033256782     PISSN: 00166758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Friedmann T. Progress toward human gene therapy // Science. 1989. V. 244. P. 4. 1275-1281.
2. Anderson W.F. Human sjene therapy // Science. 1992. V. 256. P. 808-813.
3. Culver K. W. Gene Therapy. A Handbook for Physicians. N.Y.: Mary Ann Liebert Inc. Publ.. 1994. P. 1-117.
4. Culver K.W. Gene Therapy. A Handbook for Physicians. 2nd Ed. N.Y.: Mary Ann Liebert Inc. Publ.. 1996. 185 p.
5. Mabel E.G. Gene therapy for cardiovascular diseases // Circulation. 1995. P. 541-548.
6. Sandhu J.S., Keating A.. Hozunii N. Human Gene Therapy//Critical Rev. in Biotechnol. 1997. V. 17. P. 307326.
7. Wadman M. Gene therapy pushes on despite doubts // Nature. 1999. V. 397. P. 94.
8. 3e.it'HUH A.B. FcHHaa repaniiH :ia6oJieBaHiift cocyAOB // Bonp. oHOMCfl. XHMMH. 1999. B neiiaTn.
9. Norman K. Berg conference favors use of weak strains // Nature. 1975. V. 254. P. 6-7.
10. Timmons A.M., Charters Y.M., Crawford J.M. eî al. Risks from transaenic crops // Nature. 1999. V. 380. P. 487.
11. Walters L.. Palmer J.G. The ethics of human gene therapy. Oxford Univ. Press, 1966. 195 p.
12. Pollack R. Genetics and euaenics // Nature biotechnol. 1996. V. 14. P. 1305.
13. Hedqecol A.M. Gene therapy // Encyclopedia of applied ethic / Ed. Chadwick R. L.: Acad. Press. 1998. V. 2. P. 383-390.
14. Marcel T.. (ïraus:.J.D. The TMC worldwire gene therapy enrollment report end 1996 // Human gene therapy. 1997. V. 8. P. 775-780.
15. Gene therapy / Eds Lattime E.G.. Gerson S.L. // Seminars in Oncology. 1995. V. 23. 197 p.
16. Addendum to The Points to consider human somatic cell and sene therapy ( 1991 ) // Human uene therapy. 1996. V. 7. P. 1181-1190.
17. Regulatory Issues. Department of Health and Human Services, National Institutes of Health. Recombinant DNA Advisory Committee: Minutes of Meeting // Human gene therapy. 1997. V. 8. P. 1955-1904.
18. Clinical Protocol. Phasel/IB study of immunization with autologous tumor cells transfected with the GM-CSF gene by particle-mediated transfer in patients with melanoma or sarcoma // Human gene therapy. 1997. V. 8. P. 875-891.
19. Clinical Protocol. Phase I study of vaccination with autologous irradiated malanoma cells engineered to secrete human granulocyte-macrophage colony stimulating factor // Human gene therapy. 1997. V. 7. P. 111-123.
20. Anderson F. End-of-the-Year Potpourri - 1996 // Human gene therapy. 1996. V. 7. P. 2201-2202.
21. Nevin N.C. Experience of gene therapy in the United Kingdom//Ann. N.Y. Acad. Sci. 1998. V. 862. P. 184187.
22. Wilson C.A., Ng T.-H., Miller A.E. Evaluation of recommendations for replication-competent retrovirus testing associated with use of retroviral vectors // Human gene therapy. 1997. V. 8. P. 869-874.
23. Long Z., Li L.-P., Grooms T. et al. Biosafety monitoring of patients receiving intracerebral injections of murine retroviral vector producer cells // Human gene therapy. 1998. V. 9. P. 1165-1172.
24. A pilot study of idiotypic vaccination for follicular B-cell lymphoma using a genetic approach. Clinical protocol // Human gene therapy. 1997. V. 8. P. 1287-1299.
25. Fletcher J.C., Richter G. Human fetal gene therapy // Human gene therapy. 1996. V. 7. P. 1605-1614.
26. Senior K. In utero gene therapy: one step cloaer to reality // Mol. med. today. 1998. V. 4. P. 505.
27. Embank J. Problems of germlime gene therapy // Nature. 1998. V. 392. P. 645.
28. McLaren A. Problems of germlime gene therapy // Nature. 1998. V. 392. P. 645.
29. Warman M. Germline gene therapy must be stared excessive regulation // Nature. 1998. V. 392. P. 317.
30. Schneider H., Coutelle C. In utero gene therapy: the case for // Nature Med. 1999. V. 5. P. 256-257.
31. Billings P.R. In utero gene therapy: the case against // Nature Med. 1999. V. 5. P. 255-256.